Holen Sie sich die Stockscreener-App
3.11
6.87%
0.20
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
132.49%
1.8014
|
0.7748 | 0.7069 | 0.6135 | 0.9833 |
| Interest Income/Expense |
74.75%
0.000457
|
0.00181 | 0.00314 | 0.00443 | 0.00105 |
| Operating Income/Loss |
132.49%
-1.8014
|
-0.7748 | -0.7069 | -0.6135 | -0.9833 |
| Income/Loss From Continuing Operations Before Tax |
155.31%
-1.9804
|
-0.7757 | -0.7096 | -0.6177 | -0.986 |
| Income/Loss From Continuing Operations After Tax |
155.31%
-1.9804
|
-0.7757 | -0.7096 | -0.6177 | -0.986 |
|
Net Income/Loss
|
155.31%
-1.9804
|
-0.7757 | -0.7096 | -0.6177 | -0.986 |
| Preferred Stock Dividends And Other Adjustments |
0.0504
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
126.84%
6.1712
|
2.7205 | 2.4715 | - | 2.2493 |
| Diluted Average Shares |
126.84%
6.1712
|
2.7205 | 2.4715 | - | 2.2493 |
| Basic Earnings Per Share |
13.79%
-0.33
|
-0.29 | -0.29 | -0.27 | -0.44 |
| Diluted Earnings Per Share |
13.79%
-0.33
|
-0.29 | -0.29 | -0.27 | -0.44 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.0504
|
- | - | - | - |
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):